Veterinary Medicines

AVIPRO ND LA SOTA, λυοφιλοποιημένο υλικό για οφθαλμορρινικό εναιώρημα/ για χορήγηση με πόσιμο νερό

Authorised
  • Newcastle disease virus, strain La Sota, Live
Download as PDF

Product identification

Medicine name:
AVIPRO ND LA SOTA, λυοφιλοποιημένο υλικό για οφθαλμορρινικό εναιώρημα/ για χορήγηση με πόσιμο νερό
Active substance:
  • Newcastle disease virus, strain La Sota, Live
Target species:
  • Chicken
  • Turkey
Route of administration:
  • Oral use
  • Oculonasal use

Product details

Active substance and strength:
  • Newcastle disease virus, strain La Sota, Live
    1000000.00
    50% Embryo Infective Dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate for oculonasal suspension/use in drinking water
Withdrawal period by route of administration:
  • Oral use
    • Chicken
    • Turkey
  • Oculonasal use
    • Chicken
    • Turkey
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD06
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Greece
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone)
Marketing authorisation holder:
  • Lohmann Animal Health GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Lohmann Animal Health GmbH
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 31813/31-03-2023/K-0176705
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Greek (PDF)
Published on: 6/03/2025
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Greek (PDF)
Published on: 6/03/2025
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."